RU2012148908A - Новый синтез соединений тиазолидиндиона - Google Patents
Новый синтез соединений тиазолидиндиона Download PDFInfo
- Publication number
- RU2012148908A RU2012148908A RU2012148908/04A RU2012148908A RU2012148908A RU 2012148908 A RU2012148908 A RU 2012148908A RU 2012148908/04 A RU2012148908/04 A RU 2012148908/04A RU 2012148908 A RU2012148908 A RU 2012148908A RU 2012148908 A RU2012148908 A RU 2012148908A
- Authority
- RU
- Russia
- Prior art keywords
- formula
- compound
- alkyl
- alkoxy
- halogen
- Prior art date
Links
- 0 *OC(CS1)=NC1=O Chemical compound *OC(CS1)=NC1=O 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N c1ccccc1 Chemical compound c1ccccc1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/51—Acetal radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32550210P | 2010-04-19 | 2010-04-19 | |
| US61/325,502 | 2010-04-19 | ||
| US32749810P | 2010-04-23 | 2010-04-23 | |
| US61/327,498 | 2010-04-23 | ||
| PCT/US2011/032822 WO2011133442A1 (en) | 2010-04-19 | 2011-04-18 | Novel synthesis for thiazolidinedione compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012148908A true RU2012148908A (ru) | 2014-05-27 |
Family
ID=44148625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012148908/04A RU2012148908A (ru) | 2010-04-19 | 2011-04-18 | Новый синтез соединений тиазолидиндиона |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8937182B2 (enExample) |
| EP (1) | EP2560956B1 (enExample) |
| JP (1) | JP2013525355A (enExample) |
| KR (1) | KR101781665B1 (enExample) |
| CN (1) | CN102947269B (enExample) |
| AU (1) | AU2011242956B2 (enExample) |
| CA (1) | CA2796437C (enExample) |
| DK (1) | DK2560956T3 (enExample) |
| ES (1) | ES2610623T3 (enExample) |
| HU (1) | HUE030263T2 (enExample) |
| MX (1) | MX2012012092A (enExample) |
| NZ (1) | NZ602883A (enExample) |
| PL (1) | PL2560956T3 (enExample) |
| RU (1) | RU2012148908A (enExample) |
| WO (1) | WO2011133442A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2802733C (en) * | 2010-06-24 | 2017-11-21 | Alkermes Pharma Ireland Limited | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| WO2012021476A1 (en) * | 2010-08-10 | 2012-02-16 | Metabolic Solutions Development Company, Llc | Novel synthesis for thiazolidinedione compounds |
| RU2594725C2 (ru) | 2010-08-10 | 2016-08-20 | МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи | Синтез соединений тиазолидиндиона |
| TWI773657B (zh) | 2015-12-18 | 2022-08-11 | 美商亞德利克斯公司 | 作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物 |
| US12084472B2 (en) | 2015-12-18 | 2024-09-10 | Ardelyx, Inc. | Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists |
| US20210038566A1 (en) | 2018-02-08 | 2021-02-11 | Enyo Pharma | Use of modulators of neet proteins for the treatment of infection |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| US5143930A (en) | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| SK109993A3 (en) * | 1991-04-11 | 1994-12-07 | Upjohn Co | Thiazolidinedione derivatives producing and use thereof |
| NO302471B1 (no) * | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
| JPH07188227A (ja) * | 1993-12-24 | 1995-07-25 | Japan Tobacco Inc | チアゾリジン誘導体及びオキサゾール誘導体 |
| SE9702305D0 (sv) | 1997-06-17 | 1997-06-17 | Astra Ab | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| AP869A (en) * | 1998-01-05 | 2000-09-04 | Pfizer | 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents. |
| US7407978B2 (en) | 1999-04-06 | 2008-08-05 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US6768008B2 (en) * | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| FR2817144B1 (fr) | 2000-11-29 | 2003-01-03 | Micro Mega Sa | Sequence d'instruments canalaires pour l'execution d'un protocole operatoire d'endodontie |
| WO2003029251A1 (en) * | 2001-09-28 | 2003-04-10 | Biocon Limited | Novel process for the synthesis of thiazolidinedione derivatives |
| FR2861069B1 (fr) | 2003-10-17 | 2005-12-09 | Galderma Res & Dev | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
| EP2001470A2 (en) | 2006-03-16 | 2008-12-17 | Metabolic Solutions Development Company | Combination therapies of thiazolidinedione analogues |
| MX356584B (es) | 2006-03-16 | 2018-06-05 | Metabolic Solutions Dev Co | Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica. |
| PL2001469T3 (pl) | 2006-03-16 | 2012-10-31 | Metabolic Solutions Dev Co Llc | Analogi tiazolidynodionu |
| AU2007326395B2 (en) * | 2006-12-01 | 2012-10-11 | Msd K.K. | Novel phenyl-isoxazol-3-ol derivative |
| WO2008118327A1 (en) * | 2007-03-23 | 2008-10-02 | University Of Toledo | Conformationally restrained epothilone analogues as anti-leukemic agents |
| NZ597381A (en) * | 2007-09-14 | 2013-03-28 | Metabolic Solutions Dev Co Llc | Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases |
| WO2009148195A1 (en) * | 2008-06-02 | 2009-12-10 | Daebong Ls, Ltd. | 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same |
| WO2011133441A2 (en) | 2010-04-19 | 2011-10-27 | Metabolic Solutions Development Company | Novel synthesis for thiazolidinedione compounds |
| RU2594725C2 (ru) | 2010-08-10 | 2016-08-20 | МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи | Синтез соединений тиазолидиндиона |
| WO2012021476A1 (en) | 2010-08-10 | 2012-02-16 | Metabolic Solutions Development Company, Llc | Novel synthesis for thiazolidinedione compounds |
-
2011
- 2011-04-18 WO PCT/US2011/032822 patent/WO2011133442A1/en not_active Ceased
- 2011-04-18 DK DK11716155.4T patent/DK2560956T3/en active
- 2011-04-18 EP EP11716155.4A patent/EP2560956B1/en active Active
- 2011-04-18 RU RU2012148908/04A patent/RU2012148908A/ru not_active Application Discontinuation
- 2011-04-18 CN CN201180030253.8A patent/CN102947269B/zh not_active Expired - Fee Related
- 2011-04-18 JP JP2013506202A patent/JP2013525355A/ja active Pending
- 2011-04-18 AU AU2011242956A patent/AU2011242956B2/en not_active Ceased
- 2011-04-18 PL PL11716155T patent/PL2560956T3/pl unknown
- 2011-04-18 MX MX2012012092A patent/MX2012012092A/es active IP Right Grant
- 2011-04-18 HU HUE11716155A patent/HUE030263T2/en unknown
- 2011-04-18 KR KR1020127030070A patent/KR101781665B1/ko not_active Expired - Fee Related
- 2011-04-18 ES ES11716155.4T patent/ES2610623T3/es active Active
- 2011-04-18 CA CA2796437A patent/CA2796437C/en active Active
- 2011-04-18 US US13/641,917 patent/US8937182B2/en active Active
- 2011-04-18 NZ NZ602883A patent/NZ602883A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013525355A (ja) | 2013-06-20 |
| WO2011133442A1 (en) | 2011-10-27 |
| KR20130051945A (ko) | 2013-05-21 |
| CN102947269A (zh) | 2013-02-27 |
| PL2560956T3 (pl) | 2017-03-31 |
| CN102947269B (zh) | 2015-11-25 |
| CA2796437A1 (en) | 2011-10-27 |
| AU2011242956A1 (en) | 2012-11-01 |
| US8937182B2 (en) | 2015-01-20 |
| EP2560956A1 (en) | 2013-02-27 |
| MX2012012092A (es) | 2012-12-17 |
| ES2610623T3 (es) | 2017-04-28 |
| NZ602883A (en) | 2014-09-26 |
| HK1178155A1 (en) | 2013-09-06 |
| EP2560956B1 (en) | 2016-10-26 |
| DK2560956T3 (en) | 2017-01-23 |
| US20130204004A1 (en) | 2013-08-08 |
| AU2011242956B2 (en) | 2015-01-22 |
| HUE030263T2 (en) | 2017-04-28 |
| KR101781665B1 (ko) | 2017-09-25 |
| CA2796437C (en) | 2018-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012148908A (ru) | Новый синтез соединений тиазолидиндиона | |
| CA2796872A1 (en) | Novel synthesis for thiazolidinedione compounds | |
| UA101482C2 (ru) | Способ получения 2'-дезокси-5-азацитидина (децитабина) | |
| RU2012138259A (ru) | Способ получения ривароксабана | |
| JP2008511659A5 (enExample) | ||
| IN2014CN02562A (enExample) | ||
| US6706925B2 (en) | Process for preparing bisallylboranes and nonaromatic boronic acids | |
| WO2007091009A3 (en) | Preparation of delmopinol | |
| PH12014500260A1 (en) | Aniline type compounds | |
| AU2012212508B2 (en) | Methods of making HIV attachment inhibitor prodrug compound and intermediates | |
| AU2010326429B2 (en) | Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor NOT modulators | |
| SG170794A1 (en) | Process for preparation of hiv protease inhibitors | |
| WO2009118473A3 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
| JP2013525355A5 (enExample) | ||
| MA32530B1 (fr) | Dérivés de spirocétals cristallins et procédé pour la préparation de dérivés de spirocétals | |
| EP1849788A8 (en) | Organosilicon compound | |
| RU2015111236A (ru) | Способ получения производного оксазола | |
| ATE548375T1 (de) | Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung | |
| MX2010001512A (es) | Nuevo procedimiento de preparacion. | |
| RU2013110311A (ru) | Синтез соединений тиазолидиндиона | |
| RU2013150969A (ru) | Промежуточное соединение для синтеза каспофунгина и способ его получения | |
| WO2007049295A3 (en) | An improved one pot process for making key intermediate for gemcitabine hcl | |
| KR880007490A (ko) | 치환된 아미노프로피온아미드, 이의 제조방법, 이를 함유하는 약제, 이의 용도 및 이의 제조시에 생성된 중간체 | |
| DK1701942T3 (da) | Inhibitorer for ikke-nukleotid revers transkriptase | |
| JP2009526015A5 (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20151109 |